Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation

Area of Science:

• Genetics
• Pharmacology
• Addiction Science

Background:

• The alpha4beta2 nicotinic acetylcholine receptor is crucial for tobacco dependence.
• The alpha7 nicotinic receptor may also influence smoking behavior.

Purpose of the Study:

• To investigate the association between 8 single nucleotide polymorphisms (SNPs) in nicotinic acetylcholine receptor subunit genes (alpha4, alpha7, beta2) and smoking abstinence.
• To analyze genetic variations in relation to smoking cessation success in a clinical trial cohort.

Main Methods:

• Candidate gene study involving 925 smokers from the UK.
• Participants received 8-week transdermal nicotine replacement therapy.
• Genotyping of 8 SNPs in nicotinic acetylcholine receptor subunit genes (CHRNA4, CHRNE, CHRNB2).

Main Results:

• No statistically significant associations were found between the selected SNPs and smoking cessation success at 4, 12, 26, or 52 weeks.
• Nicotine intake, assessed by plasma cotinine levels, was not significantly associated with any of the studied SNPs.
• The SNP rs2273502 showed a consistent, though not statistically significant, trend towards increased odds of smoking abstinence.

Conclusions:

• The studied single nucleotide polymorphisms (SNPs) in nicotinic acetylcholine receptor genes did not provide compelling evidence for association with smoking abstinence.
• Further investigation into the potential role of rs2273502 in smoking cessation is recommended.